by Bettina Hanika | Feb 3, 2026 | Press Releases
Schönefeld, Germany, 3 February 2026 – Kupando, a pioneering biopharmaceutical company developing a TLR 4/7 agonist that stimulates innate immunity and induces trained immunity for use in oncology and infectious diseases, today announced the appointment of Jörn Aldag...
by Bettina Hanika | Sep 26, 2022 | Press Releases
Financing led by Remiges Ventures, co-led by LifeCare Partners, with additional investments by Brandenburg Kapital, High-Tech Gründerfonds, Ventura Biomed Investors and undisclosed family offices. Proceeds to be used to complete IND-enabling work and initiate clinical...
